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The Portuguese version 
of the EORTC QLQ-C30 
P. FERREIRA 
Scltool of Ecotlomics, University of Cointbra (P) 
In this paper we repon the results of a study aimed at translating and culturally 
validating the quality of life instrument QLQ-C30 initially developed by the 
European Organization for Research and Treatment of Canccr (EORTC). 
We begin by mentioning the forward-backward translations process used to 
construct a Portuguese version semantically equivalent to the original version. After 
minor revisions, the instrument was pilot tested in fifteen patients with breast 
cancer. A brief description of the results of the pilot test with women with breast 
cancer and with other two studies (mastectomized women and women with 
lymphomas) is presented in this paper as \veil as the results of the comparison with 
the other generic and specific outcome instruments. 
\Ire conclude by referring the clinical relevance and the utility of the Portuguese 
version of the EORTC QLQ-C30 and by emphasizing thc need for further evidence 
on the interpretability of the instrument. 
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INTRODUCTION 
In the last few years the focus of measurement has been moving from the traditional 
biological indicators to more encompassing lneasures also including physical health, 
mental health and social health. We have been moving towards the concept of 
quality of life. 'Heallh related quality of lifc measures have been developed and 
validated in numerous situations and for several purposes. 
The EORTC QLQ-C30 is a good example of a psychometrically robust measure 
especially designed by the European Organization for Research and Treatment of 
Cancer for evaluating the quality of life of patients pallicipating in international 
clinical trials (Aaronson et al., 1993). In fact, in 1986, the EORTC decided to 
initiate a research program aimed at developing a core questionnaire with general 
questions about physical, emotional and social health and also specific questions 
related to symptoms suffered by cancer patients regardless of their more precise 
diagnostic. One year latter, a first version of that questionnaire was built and an 
international field testing was (Aaronson et al., 1991). After minor psychometric 
revisions, the final version with 30 questions was drawn, implemented and 
validated. 
It is composed by nine multi-item scales (including five functional scales, one 
general quality of life scale and three general symptoms scales) and six single item 
scales corresponding to additional specific symptoms usually referred by cancer 
patients (Aaronson et al., 1987). Figure 1 presents the cqnceptual structure of these 
scales. This instrument constitutes a core questionnaire to be used with other more 
specific ones. 
Fig. 1. Conceptual structure of the EORTC QLQ-C30 
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MATERIALS AND METHODS 
The process of cultural adaptation to Portuguese followed three main stcps 
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extensively explained elsewhere (Rosete c Fcrreira, 1996). In the first step, wc used 
the forward-backward translation procedure. The original questionnaire, written in 
English, was independently translated by two individuals, native spcakers in 
Portuguese with a high level of fluency in English. Then, both forward translations 
were compared in a meeting with both translators and the National Coordinator 
(myself) and some disagreements were arbitrated. This process resulted in a 
provisional forward translation which was given to two native English speakers 
with a high level of fluency in Portuguese who independently performed the 
backtranslations. Both English translations were then compnrcd by the National 
Coordinator who, before ending the meeting, showed the original English version 
to the translators and initiated a second discussion. Some revisions were made. 
In a second step, the translated questionnaire was pilot-tested with 15 breast cancer 
patients who were present for consultation at the Ambulatory Unit of a Maternity. 
Because of somc logistic constraints (lack of an available waiting room) we had to 
administer the questionnaire in a separate office. The patients were called by the 
nurse in charge of the ambulatory unit, were asked to fill the questionnaire and then 
were interviewed. The interviewer assessed, question by question, whether it had 
been difficult to answer, confusing, difficult to understand or whether the patient 
would have asked the question in a different way. Patients' general reactions to the 
pilot test were very good. A second version of the forward translation was finished 
after this pilot test. 
Neil Aaronson, the main author of the instrument, and a specialist from the Scllool 
of Medicine in Lisbon, commented on our report and finally agreed on the final 
modified version. 
Several psychometric tests were performed. Among these we can emphasize the 
confirmation of the hypothesized scales by using the multi-method technique, the 
test of reliability (or internal consistency) through the use of the Cronbach's alpha 
Table 1 -Means, standard deviations and reliability scores 
# of Items Mean SD Cronbach's 
Functioning scales 
PF -khysical 
RF - Role 
CF - Cognitive 
EF - Emotional 
SF - Social 
QL - Global quality of life 
Symptom scales andlor items 
FT - Fatigue 
NV - Nausea and vomiting 
PN - Pain 
DY - Dyspnea 
SD - Sleep disturbance 
AI&- Appetite loss 
CP - Constipation 
DR - Diarrhea 
FI - Financial impact 
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coefficient, and the test of the validity with the examination of [lie corrclalions 
among the various QLQ-C30 scales, the acceptability of patients ilnd physicians, 
and thc comparison of this instrument's results with the ones produced by other 
instruments. In the current paper we restrain our results to the descriptive and 
correlation statistics. 
RESULTS AND CONCLUSIONS 
We implemented this questionnaire in three groups of women: \vith lymphomas, 
mastectomized and with diagnosed breast cancer. Table 1 shows the means and 
standard deviations for the several scales as well as the reliability coefficients. 
Figures 2 and 3 represent the mean scorcs for the scales corresponding to each 
group of patients. 
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Figure 2 -Mean scores for three types of cancer patients 
We also performed an ANOVA to detect how significant the differences of the three 
scores obtained for each scale were. We found that the scales PF, PN, DY, AL, CP 
and FI were statistically significant (pc0.05). These results show how sensitive this 
instrument is for the different kinds of cancer patients. The reliability coefficient 
ranged from 0.425 1 for the RF scale to 0.9 193 for the NV scale. This evidences the 
internal consistency of the instrument. 
We conclude by referring the clinical relevance and the utility of the Portuguese 
version of the EORTC QLQ-C30 and emphasizing the need for furtiler evidence on 
the interpretability of the instrument 
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Gostarfarnos dc conhcccr alguns pormcnorcs sobrc si c a sua sadde. Rcsponda. por favor. a todm as 
pcrguntas hzcndo urn circulo 31 volts do ndmcro quc mclhor sc aplica ao scu caso. NBo 115 rcspostas 1 
ccfmas ncm erradas. A infonnaqb iomwida 6 eskritamentc confidencial. 1 
Escrcva: As iniciais do scu nomc ..................................................................... 
A data dc naximcnto (dia, mfs, ano) ... .............................. ...... . ... , . . .... . . 
A data dc hojc (dia, n16s. ano) .. . ... .. ........ .... ..... ... ..... .. .. ... .. . ... ... . .... .. ... . . . 
Niio S i m  
1 . Scntc dificulddc quando faz csrorqos mais violcnlos, por cxemplo, carrcgar I 2 
um saco de compras pesado ou uma mala? 
2 .  Custa-lhc andar a p6 uma grande distancia? 1 2  
3. Custa-lhe andar a pO, fora de casa, uma pequena distfincia? 1 2  
4.  Tem de lieu na cama ou numa cadeira a maior panc do dia? 1 2  
5 . Precisa que o h  ajudem a comer, a vcstir-sc, a lavar-sc ou a ir casa dc banho? 1 2 
6. Scntc-sc dc alguni mod0 limitadola para dcsempenhar o seu trabalho? 1 2  
7 .  Bd complctamcnte incapacitildola para dcscmpcnhar o scu vabalho ou tarcfas 1 2 
dombticas? 
Durante a dltima semana 
8 . Tevc faka de ar.? 
9 . Tevc do=? 
1 0. Precisou dc dcscansar? 
1 1. Dormiu mal? 
1 2. Scntiu-se fracda? 
1 3. Tevc falta dc apetitc? 
14. Tcvc cnjoos? 
4 
15.  Vomitou? 
16.  Tcvc priao dc venlrc? 
Urn 
pouco 
2 
2 
2 
2 
2 
2 
2 
2 
2 
Mui to  
Durantc n i l t imn scniann 
1 7. Tcvc dimcia? 
18. Scntiu-sc cansadda? 
19. As dorcs pcriurban~u as suas actividadcs 
dikias? 
2 0.  Tcvc diliculdadc cni conccntrar-sc, por 
cxcmplo, para Icr o jornal ou vcr tclcvis50? 
2 1. Scntiu-se tcnsola? 
2 2. Tcvc prcocupac&s? 
2 3. Scniiu-sc irrit6vcl? 
2 4. Scniiu-sc dcprimidola? 
2 5. Tcrc dificuldadc crn Icmbnr-sc das coisas? 
26. 0 seu csiado fisico ou lratarncnio mCdico 
intcrfcrirarn na sua vida familiar? 
2 7. 0 scu cstado fisico ou irainmcnto mCdico 
inicrrcrirarn na sua aciividadc social? 
L 8. 0 scu cstado fisico ou tratalncnto mCdico I 
causaram-lhc problcmas dc ordcm linanccira? 
NBo Urn Dastiintc h l u i t o  
p o u c o  
I 2 3 
2 3 
2 3 
Nas perguntas que se seguem faqa um circulo h volta do n6rncr0, cntrc I c 7 ,  
que nielhor se  aplica ao seu caso. 
29. Como class~ficaria o scu cstado fisico cm gcral durantc a bltima sc~nana? 
I 2 3 4 5 6 
PBssimo 
30. Como classilicaria a sua qualidade de vida durante a Sl~ima scmana? 
1 2 3 4 5 G 7 
PCssima 6ptima 
